| ±¸ºÐ |
NO |
¿¬±¸ Ã¥ÀÓÀÚ |
°úÁ¦¹øÈ£ |
°úÁ¦¸í |
ºñ°í |
Àü·«
°úÁ¦ |
1 |
¹ÚÁØ¿ø |
3PD0502201 |
°Ô³ðÇаú
´Ü¹éÁúüÇÐÀ» À§ÇÑ ³ª³ë¼öÁØ¿¡¼ Á¶ÀýµÈ Ç¥¸é |
¹ÚÁØ¿ø±³¼ö |
| 3PD0502202 |
ÃÖ°ü¿ë±³¼ö |
| 2 |
¾ÈÁøÈï |
3PD0502301 |
º
T-DNA »ðÀÔµ¹¿¬º¯ÀÌ ¶óÀÎÀ¸·ÎºÎÅÍ metabolic analysis¸¦
ÅëÇÑ functional genomics ¿¬±¸ ¹× ½Å±â´É¼º ºÇ°Á¾
°³¹ß |
|
| 3 |
¼º¿µÃ¶ |
3PD0502401 |
¿ø¼þÀÌ
¸ðµ¨¿¡¼ (SIVmac-macaque) sGX-109ÀÇ È¿´É Å×½ºÆ® |
|
| 4 |
·ù¼ºÈ£ |
3PD0502501 |
¸®°£µå
°³¹ß ÀÌ´Ï¼ÅÆ¼ºê ±¸Ãà |
|
| Çõ½Å°úÁ¦ |
5 |
¹ÚÁ¾¹® |
3PD0500101 |
Metabolomics¿Í
Proteomics¸¦ ÀÌ¿ëÇÑ sanguinarineÀÇ »ý»ê¼º ¾ÈÁ¤È¿¡
°üÇÑ ¿¬±¸ |
|
| 6 |
±èº´Çö |
3PD0500201 |
¸®Æ÷Á»°ú
¼öÈÁ©À» ÀÌ¿ëÇÑ ¾à¹° Àü´Þ ±â¼ú °³¹ß |
|
| 7 |
±â°æÅ |
3PD0500301 |
È÷½ºÅ¸¹Î
¼ö¿ëü ƯÀÌÀû Ȱ¼º ¾ïÁ¦ ½Å¾à°³¹ß |
|
| 8 |
½Å½Â±¸ |
3PD0500401 |
Áú·®ºÐ¼®±â¸¦
ÀÌ¿ëÇÑ ÆéŸÀ̵å Áú·®¸ÊÇÎ, ¼¿ºÐ¼® ¹× Á¤·®È¸¦ À§ÇÑ Æ®¸³Æ½ ÆéŸÀ̵åÀÇ
ÈÇк¯Çü |
|
| 9 |
Àå½Â±â |
3PD0500501 |
CÇü
°£¿° ¹ÙÀÌ·¯½ºReplicon±â¼úÀ» ÀÌ¿ëÇÑ Ç×¹ÙÀÌ·¯½ºÁ¦ ¼±µµ¹°Áú
Ž»ö |
|
| 10 |
Â÷ÇüÁØ |
3PD0500601 |
È«ÇÕ»ý¹°Á¢ÂøÁ¦ÀÇ
À¯ÀüÇÐÀû ´ë·®»ý»ê ¿¬±¸ |
|
| 11 |
ÃÖ°ü¿ë |
3PD0500701 |
»õ·Î¿î
õ¿¬ Ç×¾ÏÁ¦ÀÇ °³¹ß |
|
| 12 |
±è±â¹® |
3PD0500801 |
Targeted
Drug Delivery Systems Based on Curubitruil-Liposome |
½Å±Ô°úÁ¦ |
| 13 |
À¯ÁÖ¿¬ |
3PD0500901 |
Identification
of Anti-inflammatory Mediators of Acute
Phase Response |
½Å±Ô°úÁ¦ |
| 14 |
¾È±³ÇÑ |
3PD0501001 |
Development
of Migration/Homing Agents for Stem-Cell
Therapy of Ischemic Heart Disease |
½Å±Ô°úÁ¦ |
| 15 |
À̵¿±â |
3PD0501101 |
Efficient,
cell type-specific drug delivery using
cell-penetrating oligonucleotides |
½Å±Ô°úÁ¦ |
| 16 |
³²È«±æ |
3PD0501201 |
Chemical
Genomics ¿¬±¸¸¦ ÅëÇÑ ½Ä¹°»ýÀåÁ¶ÀýÁ¦ ¹× °³ÈÁ¶ÀýÁ¦ °³¹ß |
|
| 17 |
ÀÌ¿µ¼÷ |
3PD0501301 |
½Ä¹°ÀÌ¿ë
ȯ°æÁ¤È¸¦ À§ÇÑ À¯ÀüÀÚ¿Í ½Ä¹°°³¹ß |
|
| 18 |
Á¤¼º±â |
3PD0501401 |
»ý¸®È°¼º
ÈÇÕ¹°ÀÇ ¼¼Æ÷¸· Åõ°ú¸¦ ÃËÁøÇÏ´Â Molecular TransporterÀÇ
¼³°è ¹× ÇÕ¼º¿¬±¸ |
|
| 19 |
äġ¹ü |
3PD0501501 |
½Å°³³ä
Ä¡¸ÅÄ¡·áÁ¦ °³¹ß ¿¬±¸ |
|
| ±â¹Ý°úÁ¦ |
20 |
·ù¼ºÈ£ |
3PD0501601 |
»ýü
ºÐÀڴپ缺 Ž»ö ¹× ºÐ¼® ±â¹Ý ±â¼ú |
|
| 21 |
±è¸¸ÁÖ |
3PD0501701 |
³ª³ë¹ÙÀÌ¿À
±â¹Ý ±â¼ú |
|
| 22 |
¾ÈÁøÈï |
3PD0501801 |
º
À¯Àüü ±â´É ºÐ¼®À» À§ÇÑ ±â¹Ý ¼ºñ½º ¿î¿ë |
|
| 23 |
¹ÚÁØ¿ø |
3PD0501901 |
¼¾ÅÍ
°øµ¿ ¿¬±¸±â±â ¿î¿ë |
½Å±Ô°úÁ¦ |
| 24 |
¼º¿µÃ¶ |
3PD0502001 |
In
vivo CTL ±â¼ú°ú tumor modelÀ» ÀÌ¿ëÇÏ¿© ¼Òµ¿¹°
¸ðµ¨¿¡¼ ¹é½ÅÀÇ ¹æ¾î ¸é¿ª ÃøÁ¤ ½Ã½ºÅÛ °³¹ß |
|
| 25 |
Àå½Â±â |
3PD0502101 |
°øÅë±â¹Ý
ÀåºñÀÇ ¿î¿ë |
|